CMS 计划对暂停 Elevance 的医疗保险优势药物计划的注册进行制裁

路透中文
Mar 02
CMS 计划对暂停 Elevance 的医疗保险优势药物计划的注册进行制裁

路透3月2日 - 周一的一份文件显示,美国医疗保险与医疗补助服务中心(Centers for Medicare & Medicaid Services)已通知 Elevance Health ELV.N,计划对该医疗保险公司实施制裁,阻止其医疗保险优势处方药计划的会员注册。

除非该机构认定所发现的问题已得到圆满解决,否则制裁措施将于2026年3月31日生效。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10